SB 419 overhauls Oregon’s corporate excise tax rules for multinational and other unitary businesses by replacing the state’s existing consolidated-return framework with a combined-reporting system for taxpayers engaged in a unitary business. The bill requires combined reporting for corporations in a unitary business, sets rules for determining combined-group income, apportionment, losses, intercompany transactions, dividends, partnership income, and filing convenience elections, and directs the Department of Revenue to adopt implementing rules. It also updates related corporate tax provisions, including estimated tax payments, minimum tax calculations, dividend subtraction rules, excess loss treatment, and special rules for insurers, disaster-response businesses, and small-employer health carriers.
A major fiscal feature of the bill is that it ties the tax changes to a new Perinatal, Child and Maternal Health Fund. Beginning with tax years starting on or after January 1, 2026, the Department of Revenue must estimate the increase in revenue attributable to the bill’s tax changes and transfer that amount to the fund. The fund is continuously appropriated to the Oregon Health Authority to support prenatal, birth, postpartum, and early-childhood programs, with emphasis on children under age seven and the first year of life.
The bill would repeal ORS 317.705, 317.710, and 317.715, which are the current statutes governing Oregon’s consolidated corporate return rules, and replace them with new combined-reporting provisions. It also amends several other statutes to conform cross-references and tax administration rules to the new framework. In practical terms, the measure would affect multinational corporations, affiliated corporate groups, partnerships within unitary businesses, insurers, and certain health insurance carriers operating in Oregon.
The general sentiment reflected in the bill text is policy-driven and revenue-focused, with the measure framed as a way to capture additional tax revenue from multinational corporations and dedicate it to maternal and child health programs. Because there are no committee transcripts or recorded votes provided, there is no direct evidence in the supplied materials of support or opposition from legislators or stakeholders. The bill’s structure suggests an intent to pair corporate tax reform with a targeted public-health funding stream.
The main point of potential contention is the shift from existing consolidated-return rules to a broader combined-reporting regime for unitary businesses, especially where foreign corporations, out-of-state entities, and partnership income are included in the tax base. Multinational corporations and tax practitioners may view the bill as increasing compliance burdens and potentially expanding Oregon tax liability, while supporters are likely to emphasize anti-avoidance, revenue generation, and the earmarked health funding. Another possible area of debate is the use of estimated revenue gains to finance a dedicated fund, which links corporate tax policy directly to spending on family and child health services.
SB 419 would substantially revise Oregon corporate income and excise tax law by repealing the current consolidated-return statutes and replacing them with a combined-reporting system for unitary businesses. It amends multiple sections of the Oregon Revised Statutes to align tax reporting, apportionment, minimum tax, dividend subtraction, loss limitation, and administrative rules with the new framework, and it also makes conforming changes affecting insurers, disaster-response businesses, and small-employer health insurance carriers. The bill applies to tax years beginning on or after January 1, 2026, and creates a dedicated fund outside the General Fund for maternal and child health programs financed by the estimated revenue increase from the tax changes.
Based on the bill text alone, the measure appears generally supportive of stronger corporate tax collection and targeted public investment, with a clear policy goal of redirecting additional revenue to perinatal, child, and maternal health services. No committee testimony or vote history was provided, so there is no recorded legislative debate to indicate formal support or opposition. The overall tone of the bill is affirmative and programmatic rather than exploratory, suggesting a deliberate effort to pair tax reform with health funding.
The most likely points of contention are the expansion of combined reporting to multinational and unitary corporate groups, the inclusion of foreign and out-of-state entities in the reporting base, and the administrative complexity of the new apportionment and income-calculation rules. Corporate taxpayers may object to increased compliance costs, broader tax exposure, and the repeal of existing consolidated-return provisions, while supporters may argue the changes close avoidance opportunities and generate revenue for child and maternal health. The earmarking of revenue for a dedicated health fund may also draw scrutiny from those who prefer general-fund use or who question revenue estimates.